
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Frenova Renal Research has expanded its roster of Managd Clinical Research Sites. Fenova's approach to site management both reduces burden and compresses timelines. The new addition will enhance Frenova's ability to help clinical research sponsors enroll patients rapidly.
For more, click






